Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John W Rose

Showing results (1-10 of 63) with videos related to

Pageof 7
Sort By:
Neurology|July 31, 2009
Multiple sclerosis: evidence of maternal effects and an increasing incidence in womenJohn W Rose
Science Translational Medicine|August 3, 2012
Anti-CD25 immunotherapy: regulating the regulatorsJohn W Rose
CNS Drugs|June 1, 2006
Antioxidants in multiple sclerosis: do they have a role in therapy?Noel G Carlson, John W Rose
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|July 15, 2017
Daclizumab: Development, Clinical Trials, and Practical Aspects of Use in Multiple SclerosisLaura E Baldassari, John W Rose
Expert Opinion on Medical Diagnostics|March 15, 2013
Clinical biomarkers in multiple sclerosisJohn W Rose, Noel G Carlson
Expert Opinion on Medical Diagnostics|March 14, 2013
Vitamin D as a clinical biomarker in multiple sclerosisNoel G Carlson, John W Rose
Current Neurology and Neuroscience Reports|August 21, 2008
Monoclonal antibody treatments for multiple sclerosisJohn W Rose, John Foley, Noel Carlson
Current Treatment Options in Neurology|April 15, 2009
Monoclonal antibody treatments for multiple sclerosisJohn W Rose, John F Foley, Noel G Carlson
Expert Opinion on Medical Diagnostics|March 14, 2013
Optical coherence tomography as a biomarker in multiple sclerosisAnette Simble Fjeldstad, Noel G Carlson, John W Rose
Expert Review of Clinical Pharmacology|December 7, 2013
Daclizumab, an IL-2 modulating antibody for treatment of multiple sclerosisJames P Sheridan, Randy R Robinson, John W Rose
Pageof 7

Showing results (1-10 of 63) with videos related to

Sort By:
Pageof 7
Neurology|July 31, 2009
Multiple sclerosis: evidence of maternal effects and an increasing incidence in womenJohn W Rose
Science Translational Medicine|August 3, 2012
Anti-CD25 immunotherapy: regulating the regulatorsJohn W Rose
CNS Drugs|June 1, 2006
Antioxidants in multiple sclerosis: do they have a role in therapy?Noel G Carlson, John W Rose
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|July 15, 2017
Daclizumab: Development, Clinical Trials, and Practical Aspects of Use in Multiple SclerosisLaura E Baldassari, John W Rose
Expert Opinion on Medical Diagnostics|March 15, 2013
Clinical biomarkers in multiple sclerosisJohn W Rose, Noel G Carlson
Expert Opinion on Medical Diagnostics|March 14, 2013
Vitamin D as a clinical biomarker in multiple sclerosisNoel G Carlson, John W Rose
Current Neurology and Neuroscience Reports|August 21, 2008
Monoclonal antibody treatments for multiple sclerosisJohn W Rose, John Foley, Noel Carlson
Current Treatment Options in Neurology|April 15, 2009
Monoclonal antibody treatments for multiple sclerosisJohn W Rose, John F Foley, Noel G Carlson
Expert Opinion on Medical Diagnostics|March 14, 2013
Optical coherence tomography as a biomarker in multiple sclerosisAnette Simble Fjeldstad, Noel G Carlson, John W Rose
Expert Review of Clinical Pharmacology|December 7, 2013
Daclizumab, an IL-2 modulating antibody for treatment of multiple sclerosisJames P Sheridan, Randy R Robinson, John W Rose
Pageof 7